Metformin - a new approach

Pediatr Endocrinol Diabetes Metab. 2021;27(2):134-140. doi: 10.5114/pedm.2021.107166.ABSTRACTMetformin is a widely used biguanide drug recommended as a first-line antidiabetic for type 2 diabetes. Currently, metformin is used not only in the treatment of diabetes but also in other diseases. Some studies have shown that metformin causes weight loss in insulin-sensitive and insulin-resistant overweight and obese patients. Metformin is an effective and safe option for women with gestational diabetes and type 2 diabetes in pregnancy, and it may also increase the ovulation rate in patients with polycystic ovary syndrome (PCOS). Longer survival times have been observed in cancer patients using metformin. Metformin has been shown to significantly correlate with lower mortality in obese or type 2 diabetic women hospitalized for COVID-19. It also has a protective effect on the development and progression of many types of cancer. The mechanisms of action of metformin are complex and still not fully understood. Metformin has been shown to act through both AMP-activated protein kinase (AMPK)-dependent mechanisms and AMPK-independent mechanisms. This paper presents the benefits of using metformin in the treatment of various diseases.PMID:34514769 | DOI:10.5114/pedm.2021.107166
Source: Pediatric Endocrinology, Diabetes, and Metabolism - Category: Endocrinology Authors: Source Type: research

Related Links:

Pediatr Endocrinol Diabetes Metab. 2021;27(2):134-140. doi: 10.5114/pedm.2021.107166.ABSTRACTMetformin is a widely used biguanide drug recommended as a first-line antidiabetic for type 2 diabetes. Currently, metformin is used not only in the treatment of diabetes but also in other diseases. Some studies have shown that metformin causes weight loss in insulin-sensitive and insulin-resistant overweight and obese patients. Metformin is an effective and safe option for women with gestational diabetes and type 2 diabetes in pregnancy, and it may also increase the ovulation rate in patients with polycystic ovary syndrome (PCOS)....
Source: Pediatric Endocrinology, Diabetes, and Metabolism - Category: Endocrinology Authors: Source Type: research
More News: Cancer | Cancer & Oncology | COVID-19 | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Fortamet | Insulin | Metformin | Obesity | Ovaries | Pediatrics | Polycystic Ovary Syndrome | Pregnancy | Study | Weight Loss | Women